2 May 2025
💉Correction Notice for Exclusive Patent License on Drug Delivery System
Prospective Grant of an Exclusive Patent License: Size-Dependent Brain and Lymphatic Distribution of Macromolecular Drug Delivery Platform
Summary
The Department of Health and Human Services corrected a previous notice regarding a prospective grant of an exclusive patent license for a macromolecular drug delivery platform. This announcement pertains specifically to its size-dependent brain and lymphatic distribution characteristics, aiming to facilitate drug delivery innovation.
Agencies
- Health and Human Services Department
- National Institutes of Health
Business Impact
$$ - Med
The content pertains to a prospective grant of an exclusive patent license, which indicates potential financial opportunities for businesses involved in drug delivery systems. The notice implies that businesses could position themselves to benefit from the licensed technology.